Chemoinformaics analysis of isofuranogermacrene
| Molecular Weight | 216.324 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
| Exact Molecular Weight | 216.151 | nRing | 2 |
| Solubility: LogS | -4.562 | nHRing | 1 |
| Solubility: LogP | 4.448 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 21.8001 |
| QED | 0.679 |
| Synth | 4.379 |
| Natural Product Likeliness | 2.922 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.909 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.66 |
| MDCK | 0.0000274 |
| BBB | 0.248 |
| PPB | 0.938844 |
| VDSS | 2.468 |
| FU | 0.0393426 |
| CYP1A2-inh | 0.461 |
| CYP1A2-sub | 0.671 |
| CYP2c19-inh | 0.455 |
| CYP2c19-sub | 0.839 |
| CYP2c9-inh | 0.258 |
| CYP2c9-sub | 0.657 |
| CYP2d6-inh | 0.644 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.812 |
| CYP3a4-sub | 0.389 |
| CL | 9.713 |
| T12 | 0.124 |
| hERG | 0.018 |
| Ames | 0.01 |
| ROA | 0.197 |
| SkinSen | 0.046 |
| Carcinogencity | 0.563 |
| EI | 0.103 |
| Respiratory | 0.894 |
| NR-Aromatase | 0.403 |
| Antiviral | Yes |
| Prediction | 0.793479 |